Kyuhei Koda
- Hematology top 10%
- Acute Myeloid Leukemia Research 2
- Chronic Myeloid Leukemia Treatments 2
-
- Chemotherapy-induced organ toxicity mitigation 1
-
- T-cell and Retrovirus Studies 1
-
- Liver Disease Diagnosis and Treatment 2
-
- Colorectal Cancer Treatments and Studies 2
- Cancer Treatment and Pharmacology 2
-
- Gastric Cancer Management and Outcomes 2
- Co-authors
- Hisashi SakamakiMasahiro ImamuraHiroshi HaradaKingo FujimuraYasuo IkedaMasataka KuwanaShosaku� NomuraTetsuro‐Takahiro Fujimoto
- Journals
- Blood (1 paper)Clinical Chemistry (1 paper)Journal of Gastroenterology and Hepatology (1 paper)
- Partner nations
- JapanUnited StatesGreece
In The Last Decade
Kyuhei Koda
10 papers receiving 182 citations
Peers
Comparison fields: 5 of 37
- Hematology 114
- Genetics 33
- Pathology and Forensic Medicine 42
- Immunology 42
- Gastroenterology 9
Countries citing papers authored by Kyuhei Koda
This map shows the geographic impact of Kyuhei Koda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kyuhei Koda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kyuhei Koda more than expected).
Fields of papers citing papers by Kyuhei Koda
This network shows the impact of papers produced by Kyuhei Koda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kyuhei Koda. The network helps show where Kyuhei Koda may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Kyuhei Koda, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 20 | |
| 2 | 2009 | 47 | |
| 3 | 2007 | 5 | |
| 4 | 2005 | 90 | |
| 5 | [A case of chronic neutrophilic leukemia accompanied with severe bone marrow fibrosis which was effectively treated by hydroxyurea]. | 1994 | 8 |
| 6 | [Combination chemotherapy of UFT with adriamycin (ADM) and cisplatin (CDDP) for advanced gastrointestinal cancer]. | 1990 | 3 |
| 7 | [Intraperitoneal (Ip) administration of cisplatin in combination with systemic chemotherapy in patients with malignant ascites of gastrointestinal cancer: clinical evaluation and pharmacokinetics]. | 1988 | 2 |
| 8 | 1988 | 2 | |
| 9 | [Combination chemotherapy of UFT with adriamycin in advanced gastrointestinal cancer]. | 1987 | 1 |
| 10 | 1986 | 11 |
About Kyuhei Koda
Kyuhei Koda is a scholar working on Hematology, Genetics and Hepatology, having authored 10 papers that have together received 189 indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (2 papers), Liver Disease Diagnosis and Treatment (2 papers), Colorectal Cancer Treatments and Studies (2 papers), Gastric Cancer Management and Outcomes (2 papers), Cancer Treatment and Pharmacology (2 papers), Chronic Myeloid Leukemia Treatments (2 papers), Chemotherapy-induced organ toxicity mitigation (1 paper) and T-cell and Retrovirus Studies (1 paper). The work is most often cited by research in Hematology (114 citations), Genetics (33 citations) and Pathology and Forensic Medicine (42 citations). Kyuhei Koda has collaborated with scholars based in Japan, United States and Greece. Frequent co-authors include Hisashi Sakamaki, Masahiro Imamura, Hiroshi Harada, Kingo Fujimura, Yasuo Ikeda, Masataka Kuwana, Shosaku� Nomura, Tetsuro‐Takahiro Fujimoto, Yoshiyuki Kurata and Masanao Teramura. Their work appears in journals such as Blood, Clinical Chemistry, Journal of Gastroenterology and Hepatology, Biology of Blood and Marrow Transplantation and European Journal Of Haematology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.